Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

EMILY MORIARTY

Allopathic & Osteopathic Physicians Ophthalmology

NPI
1619137197
CMS profile
28064
Location
BROOKLYN, NY

General Payments · PY2018–2024

$2,632.55

  • Reported across 85 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$920.76

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $920.76 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
RxSight Inc $357.19 4
ABBVIE INC. $137.29 13
GLAUKOS CORPORATION $97.14 1
Sight Sciences, Inc. $90.00 4
Tarsus Pharmaceuticals, Inc. $70.16 4
Ocular Therapeutix, Inc. $57.21 3
Bausch & Lomb Americas Inc. $45.66 3
Harrow Eye, LLC $33.09 2
Dompe US, Inc. $33.02 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $698.44 8
PY2019 $353.72 7
PY2020 $190.72 10
PY2021 $171.17 6
PY2022 $117.50 7
PY2023 $180.24 11
PY2024 $920.76 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $4.97 01/26/2024 Food and Beverage Undisputed 01/23/2026 1105066350 CMS
ABBVIE INC. $13.20 02/09/2024 Food and Beverage Undisputed 01/23/2026 1105066352 CMS
ABBVIE INC. $9.07 03/08/2024 Food and Beverage Undisputed 01/23/2026 1105066354 CMS
ABBVIE INC. $8.14 03/15/2024 Food and Beverage Undisputed 01/23/2026 1105066356 CMS
ABBVIE INC. $9.99 03/21/2024 Food and Beverage Undisputed 01/23/2026 1105066358 CMS
ABBVIE INC. $6.71 05/10/2024 Food and Beverage Undisputed 01/23/2026 1105066360 CMS
ABBVIE INC. $3.99 06/05/2024 Food and Beverage Undisputed 01/23/2026 1105066362 CMS
ABBVIE INC. $6.94 06/26/2024 Food and Beverage Undisputed 01/23/2026 1105066364 CMS
ABBVIE INC. $8.64 07/03/2024 Food and Beverage Undisputed 01/23/2026 1105066366 CMS
ABBVIE INC. $7.76 08/28/2024 Food and Beverage Undisputed 01/23/2026 1105066368 CMS
ABBVIE INC. $4.63 08/28/2024 Food and Beverage Undisputed 01/23/2026 1105066370 CMS
ABBVIE INC. $47.60 10/19/2024 Food and Beverage Undisputed 01/23/2026 1105066372 CMS
ABBVIE INC. $5.65 11/25/2024 Food and Beverage Undisputed 01/23/2026 1105066374 CMS
Bausch & Lomb Americas Inc. $15.83 02/06/2024 Food and Beverage Undisputed 01/23/2026 1140340990 CMS
Bausch & Lomb Americas Inc. $16.05 02/23/2024 Food and Beverage Undisputed 01/23/2026 1140340992 CMS
Bausch & Lomb Americas Inc. $13.78 04/25/2024 Food and Beverage Undisputed 01/23/2026 1140340994 CMS
Dompe US, Inc. $16.03 03/04/2024 Food and Beverage Undisputed 01/23/2026 1151402635 CMS
Dompe US, Inc. $16.99 12/02/2024 Food and Beverage Undisputed 01/23/2026 1151402637 CMS
Glaukos Corporation $97.14 04/17/2024 Food and Beverage Undisputed 01/23/2026 1151978370 CMS
Harrow Eye, LLC $17.00 02/16/2024 Food and Beverage Undisputed 01/23/2026 1145610245 CMS
Harrow Eye, LLC $16.09 10/02/2024 Food and Beverage Undisputed 01/23/2026 1145610247 CMS
Ocular Therapeutix, Inc. $15.62 04/19/2024 Food and Beverage Undisputed 01/23/2026 1148198459 CMS
Ocular Therapeutix, Inc. $22.76 05/14/2024 Food and Beverage Undisputed 01/23/2026 1148198457 CMS
Ocular Therapeutix, Inc. $18.83 09/24/2024 Food and Beverage Undisputed 01/23/2026 1148198455 CMS
RxSight Inc $17.61 04/01/2024 Food and Beverage Undisputed 01/23/2026 1144222388 CMS
RxSight Inc $7.21 04/02/2024 Food and Beverage Undisputed 01/23/2026 1144222390 CMS
RxSight Inc $314.52 10/18/2024 Food and Beverage Undisputed 01/23/2026 1144222392 CMS
RxSight Inc $17.85 12/12/2024 Food and Beverage Undisputed 01/23/2026 1144222394 CMS
Sight Sciences, Inc. $15.00 01/09/2024 Food and Beverage Undisputed 01/23/2026 1151925715 CMS
Sight Sciences, Inc. $25.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 1151925721 CMS
Sight Sciences, Inc. $25.00 08/20/2024 Food and Beverage Undisputed 01/23/2026 1151925719 CMS
Sight Sciences, Inc. $25.00 12/10/2024 Food and Beverage Undisputed 01/23/2026 1151925717 CMS
Tarsus Pharmaceuticals, Inc. $15.00 03/26/2024 Food and Beverage Undisputed 01/23/2026 1139118492 CMS
Tarsus Pharmaceuticals, Inc. $17.18 09/23/2024 Food and Beverage Undisputed 01/23/2026 1139118494 CMS
Tarsus Pharmaceuticals, Inc. $18.99 09/30/2024 Food and Beverage Undisputed 01/23/2026 1139118496 CMS
Tarsus Pharmaceuticals, Inc. $18.99 11/18/2024 Food and Beverage Undisputed 01/23/2026 1139118498 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.